claiming the U.S. Food and Drug Administration unlawfully approved a lower-cost version of a drug that treats a rare autoimmune disease, rejecting Catalyst's challenge against a magistrate judge's ruling. Opinion attached I Read full article » Dillon McCandless Seeks $136K Fee From Pa. For Virus Fight